Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Kelun Group, officially known as Kelun Pharmaceutical Co., Ltd., is a prominent player in the pharmaceutical preparation manufacturing industry, headquartered in China (CN). Established in 2004, the company has rapidly expanded its operations across major regions, including Asia, Europe, and North America, solidifying its presence in the global market.
Specialising in the development and production of high-quality injectable drugs, Kelun Group is recognised for its innovative approach and commitment to research and development. The company’s core products include a diverse range of sterile injectables and oncology medications, distinguished by their advanced formulation techniques and stringent quality control measures.
With a strong market position, Kelun Group has achieved significant milestones, including numerous certifications and partnerships that enhance its reputation as a trusted provider in the pharmaceutical sector. Its dedication to excellence and patient safety continues to drive its success in the competitive landscape of pharmaceutical manufacturing.
-17 vs industry average
Kelun Group’s score of 25 is lower than 35% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Scope 3 accounts for ••• of total emissions.
Kelun Group, a Pharmaceutical Preparation Manufacturing company headquartered in CN, reported its most recent carbon emissions data for 2024. The company's Scope 1 emissions were approximately 2.36 billion kg CO2e, and its Scope 2 emissions were about 483.79 million kg CO2e. This data is inherited from its parent company, Sichuan Kelun Pharmaceutical Co., Ltd.
For 2023, Kelun Group's Scope 1 emissions were approximately 2.19 billion kg CO2e, and its Scope 2 emissions were about 468.87 million kg CO2e. In 2022, the company disclosed Scope 1 emissions from processes of approximately 12.62 million kg CO2e and Scope 3 emissions from purchased goods and services of about 472.01 million kg CO2e.
Kelun Group has not disclosed specific reduction targets or climate pledges, nor does it have Science Based Targets initiative (SBTi) commitments.
No climate goals have been disclosed for Kelun Group yet.
See all scope 3 categories
Already have an account? Sign in now


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more